Use of Self-Assembled Nanocrystals
AssigneesUniversite De Paris, Centre National de la Recherche Scientifique (CNRS)
InventorMarie Paule Pileni
Life of this patent
Estimating the term…
Abstract
The present invention relates to a self-assembled structure for use in the treatment of mammalian cancer, the structure being between 50 and 1,500 nm in size and comprising a plurality of nanocrystals chosen from metal or metal oxide nanocrystals, a plurality of ligands being covalently linked to the surface of each of the nanocrystals, the ligands comprising hydrocarbon chains. The invention also relates to an injectable composition comprising said structure.
Claims15
A self-assembled structure for use in the treatment of mammalian cancer, the said structure having a size of 50 to 1,500 nm comprises a plurality of nanocrystals selected from metal or metal oxide nanocrystals, a plurality of ligands covalently bound to the surface of each of the said nanocrystals.
The composition according to claim 12, wherein it is aqueous.
13-14. (canceled)
Dependencies are inferred from the claim text.